Frontlight ResearchEarly access
Trial site
New Taipei Municipal TuCheng Hospital
- 8running trials
- 2closed trials
The trials here
What the 10 trials at this site are about, from their registry records.
- Conditions
- Alzheimer disease5 trials
- Lung cancer3 trials
- Mild cognitive impairment2 trials
- Lewy body dementia1 trial
- Neuroendocrine tumours1 trial
- Pancreatic cancer1 trial
- Stroke1 trial
- Phase
- Phase 35 trials
- Phase 22 trials
- Status
- Active, not recruiting3 trials
- Recruiting3 trials
- Completed2 trials
- Not yet recruiting2 trials
- Lead sponsor
- Eli Lilly and Company6 trials
- Chang Gung Memorial Hospital1 trial
- Eisai Taiwan Inc.1 trial
- Stichting International Registry for Alzheimer's Disease and other Dementias Foundation1 trial
- TaiRx, Inc.1 trial
Running trials
Not yet recruiting
An Observational Study of LEQEMBI in Routine Clinical Practice in Taiwan
Recruiting
A Study of Donanemab (LY3002813) in Participants With Early Cognitive Decline (TRAILBLAZER-ALZ 7)
Recruiting
Recruiting
Active, not recruiting
A Study of Remternetug (LY3372993) in Early Alzheimer's Disease (TRAILRUNNER-ALZ 3)
Recruiting
Active, not recruiting
Active, not recruiting
Study of CVM-1118 for Patients With Advanced Neuroendocrine Tumors
Recruiting at the same time
How many trials recruit for the same indication here at once. A count, not a rating.
- Alzheimer disease3 recruiting
- Lung cancer2 recruiting
- Mild cognitive impairment2 recruiting
- Lewy body dementia1 recruiting
Closed trials
Site data: ClinicalTrials.govUpdated 19 Nov 2026